As cDC2 are much more numerous than cDC1 in tumours, current efforts to understand the biological function of newly identified cDC2 subsets states will be essential to reveal novel targets for immunotherapies aiming to restore cancer immunity. This evidence concerns the gene MPPE1 and neoplasm.